pentobarbital will minimize the level or effect of suvorexant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. Sturdy CYP3A4 inducers may perhaps reduce suvorexant efficacy; if improved suvorexant dose expected, tend not to exceed twenty mg/dayWatch Closely (two)pentobarbital will decrease the level or outcome of